Cysteine-Based Protein Adduction by Epoxide-Derived Metabolite(s) of Benzbromarone

详细信息    查看全文

• 作者：Hui Wang ; Yukun Feng ; Qian Wang ; Xiucai Guo ; Wenlin Huang ; Ying Peng ; Jiang Zheng
• 刊名：Chemical Research in Toxicology
• 出版年：2016
• 出版时间：December 19, 2016
• 年：2016
• 卷：29
• 期：12
• 页码：2145-2152
• 全文大小：416K
• ISSN：1520-5010

文摘

Benzbromarone (BBR) is a therapeutically useful uricosuric agent but can also cause acute liver injury. The hepatotoxicity of BBR is suggested to be associated with its metabolic activation. Our recent metabolic study demonstrated that BBR was metabolized to epoxide intermediate(s) by cytochrome P450 3A, and the intermediate(s) was reactive to N-acetylcysteine. The objectives of the present study were to determine the chemical identity of the interaction of protein with the epoxide intermediate(s) of BBR and to define the association of the protein modification with hepatotoxicity induced by BBR. Microsomal incubation study showed that the reactive intermediate(s) covalently modified microsomal protein at cysteine residues. Such adduction was also observed in hepatic protein obtained from liver of mice given BBR. The protein covalent binding occurred in time- and dose-dependent manners. Pretreatment with ketoconazole attenuated BBR-induced protein modification and hepatotoxicity, while pretreatment with dexamethasone or buthionine sulfoximine potentiated the protein adduction and hepatotoxicity induced by BBR. A good correlation was observed between BBR-induced hepatotoxicity and the epoxide-derived hepatic protein modification in mice. The present study provided in-depth mechanistic insight into BBR-induced hepatotoxicity.